ERASLAN, E. Et Al. 2018. Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?. Turkish Society of Physiological Sciences 44th National Physiology Congress , (Turkey).

ERASLAN, E., TOPDAĞI, Ö., TANYELİ, A., GÜLER, M. C., ŞEBİN, E., ÖZBEK ŞEBİN, S., ... POLAT, E.(2018). Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer? . Turkish Society of Physiological Sciences 44th National Physiology Congress, Turkey

ERASLAN, ERSEN Et Al. "Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?," Turkish Society of Physiological Sciences 44th National Physiology Congress, Turkey, 2018

ERASLAN, ERSEN Et Al. "Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?." Turkish Society of Physiological Sciences 44th National Physiology Congress , Turkey, 2018

ERASLAN, E. Et Al. (2018) . "Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?." Turkish Society of Physiological Sciences 44th National Physiology Congress , Turkey.

@conferencepaper{conferencepaper, author={ERSEN ERASLAN Et Al. }, title={Can Adropin and Preptin be a Prognostic Marker and aPotential Therapeutic Target in Prostate Cancer?}, congress name={Turkish Society of Physiological Sciences 44th National Physiology Congress}, city={}, country={Turkey}, year={2018}}